Dergiler / Ulusal Travma ve Acil Cerrahi Dergisi / 2018 / Cilt: 24 - Sayı: 6

Predicting critical duration and reversibility of damage in acute mesenteric ischemia: An experimental study

Akut mezenterik iskemi hasarının kritik zaman tahmini ve reversibilitesi

Sayfa
507–513
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The combination of SCUBE-1 and endocan may be useful to detect irreversible intestinal damage.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND: The objective of the current study was to investigate the value of the ischemic biomarkers endothelial cell-specific molecule-1 (endocan) and signal peptide-CUB-EGF domain-containing protein-1 (SCUBE-1) in the diagnosis and assessment of earlystage and irreversible damage in acute mesenteric ischemia.
📊
Temel Bulgular & Veri:METHODS: An experimental mesenteric ischemia reperfusion model was designed using 54 rats.
💡
Sonuç & Katkı:The combination of SCUBE-1 and endocan may be useful to detect irreversible intestinal damage.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

BACKGROUND: The objective of the current study was to investigate the value of the ischemic biomarkers endothelial cell-specific molecule-1 (endocan) and signal peptide-CUB-EGF domain-containing protein-1 (SCUBE-1) in the diagnosis and assessment of earlystage and irreversible damage in acute mesenteric ischemia. METHODS: An experimental mesenteric ischemia reperfusion model was designed using 54 rats. Nine groups were created: Three sham groups [Groups I (30th minute), IV (2nd hour), and VII (6th hour)], in which only blood and tissue specimens were sampled; 3 ischemia groups [Groups II (30th minute), V (2nd hour), and VIII (6th hour)], in which blood and tissue specimens were sampled after ligation of the superior mesenteric artery (SMA); and 3 reperfusion groups [Groups III (30th minute), VI (2nd hour), and IX (6th hour)], in which blood and tissue specimens were sampled after declamping the SMA and reperfusion for 1 hour. SCUBE-1 and endocan samples obtained from blood and tissue were examined histopathologically. RESULTS: The SCUBE-1 level was higher in the ischemia groups when compared with the sham groups (p<0.05), and the endocan level was markedly different in the late ischemia (6th hour) group. When these 2 markers were used together to assess irreversible mesenteric damage in the histopathological examination, the sensitivity in distinguishing between reversible or irreversible damage was 94.1% with a specificity of 73.7%. CONCLUSION: The elevation of SCUBE-1 alone seems to be significant for predicting early mesenteric ischemia in laboratory rats. The combination of SCUBE-1 and endocan may be useful to detect irreversible intestinal damage.

Abstract

AMAÇ: Bu çalışmada akut mezenterik iskemide yeni iskemik biyobelirteçler olan endocan ve SCUBE-1’in erken evre hasar, tanı ve irreversibıl hasar değerlerini araştırmayı amaçladık. GEREÇ VE YÖNTEM: Elli dört sıçan ile deneysel bir mezenterik iskemi reperfüzyon modeli tasarlandı. Dokuz grup oluşturuldu: Kan ve doku örneklerinin sadece örneklendiği üç sahte grup [Grup I (30. dakika), IV (2. saat) ve VII (6. saat)]; superior mezenterik arter (SMA) bağlandıktan sonra kan ve doku numuneleri örneklenen üç iskemi grubu [Grup II (30. dakika), V (2. saat) ve VIII (6. saat)]; ve SMA dekompresyonundan sonra kan ve doku numuneleri örneklendirilen ve reperfüzyon bir saat süreyle indüklenen üç reperfüzyon grubu [Grup III (30. dakika), VI (2. saat) ve IX (6. saat)]. SCUBE-1 ve endocan için kan örnekleri alındı ve histopatolojik olarak doku örnekleri incelendi. BULGULAR: SCUBE-1 düzeyleri iskemi grubunda sahte gruba göre daha yüksek iken (p<0.05), geç iskemi (6. saat) grubunda endocan düzeyleri belirgin olarak farklıydı. Bu iki belirteç, histopatolojik incelemeye göre irreversıble mezenterik hasar için birlikte kullanıldığında, reversible-irrreversible hasar ayırımını %94.1 sensitivite, %73.7 spesifite ile belirledi. TARTIŞMA: SCUBE-1’in tek başına yükselmesi laboratuvar sıçanlarında erken mezenterik iskemiyi öngörmede önemli olarak gözükmektedir. Bununla birlikte, SCUBE-1 ve endocan eş zamanlı kullanımı irreversible bağırsak hasarının tespitinde daha kullanılışlı olabilir.

🔖

Bu Makaleye Atıf Yap

AKÖZ, A., TÜRKDOĞAN, K., ÇETİN, N., KUM, S., DUMAN, A., TÜRE, M., DEMİRKIRAN, A. (2018). Predicting critical duration and reversibility of damage in acute mesenteric ischemia: An experimental study. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 24 - Sayı: 6, 507–513. https://ajindex.com/articles/323646

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Tu CF, Yan YT, Wu SY, Djoko B, Tsai MT, Cheng CJ, et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J Biol Chem 2008;283:12478–88. [CrossRef ] 2. Dai DF, Thajeb P, Tu CF, Chiang FT, Chen CH, Yang RB, et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol 2008;51:2173–80. [CrossRef ] 3. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, et al. Endocan-a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology 2014;65:773–7. [CrossRef ] 4. Menon P, Kocher ON, Aird WC. Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration. Circulation 2011;124:a15455. 5. Aparci M, Isilak Z, Uz O, Yalcin M, Kucuk U. Endocan and endothelial dysfunction. Angiology 2015;66:488–9. [CrossRef ] 6. Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, et al. Expression and distribution of endocan in human tissues. Biotech Histochem 2012;87:172–8. [CrossRef ] 7. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. Arch Intern Med 2004;164:1054– 62. [CrossRef ] 8. Cho JS, Carr JA, Jacobsen G, Shepard AD, Nypaver TJ, Reddy DJ. Longterm outcome after mesenteric artery reconstruction: a 37-year experience. J Vasc Surg 2002;35:453–60. [CrossRef ] 9. Zhao Y, Yin H, Yao C, Deng J, Wang M, Li Z, et al. Management of Acute Mesenteric Ischemia: A Critical Review and Treatment Algorithm. Vasc Endovascular Surg 2016;50:183–92. [CrossRef ] 10. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478–83. [CrossRef ] 11. Assadian A, Assadian O, Senekowitsch C, Rotter R, Bahrami S, Fürst W, et al. Plasma D-lactate as a potential early marker for colon ischaemia after open aortic reconstruction. Eur J Vasc Endovasc Surg 2006;31:470–4 12. Acosta S, Nilsson TK, Björck M. D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery. Br J Surg 2004;91:991–4. [CrossRef ] 13. Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS. Intestinal fatty acid binding protein (i-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 2006;63:322–5 [CrossRef ] 14.